MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view

Autor:	A. Natalicchio, M. Montagnani, M. Gallo, N. Marrano, A. Faggiano, M.C. Zatelli, R. Mazzilli, A. Argentiero, R. Danesi, S. D’Oronzo, S. Fogli, D. Giuffrida, S. Gori, A. Ragni, V. Renzelli, A. Russo, T. Franchina, E. Tuveri, L. Sciacca, M. Monami, G. Cirino, G. Di Cianni, A. Colao, A. Avogaro, S. Cinieri, N. Silvestris, F. Giorgino
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Cancer Research Oncology miRNAs cancer type 2 diabetes miRNA-based drugs
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e3879a980ea25b0cec710d6a54f6bf https://hdl.handle.net/20.500.11769/564330 Zobrazit plný text záznamu